Jukka Kemppainen
2 of 13
- New method of using a convolutional neural network for 2D intraprostatic tumor segmentation from PET images (2023)
- Research on Biomedical Engineering
- Tekoäly syövän molekyylikuvantamisessa (2023)
- Erikoislääkäri
- Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2023)
- European Radiology
- Cool-Water Immersion Reduces Post-Exercise Quadriceps Femoris Muscle Perfusion more than Cold-Water Immersion (2022)
- Medicine and Science in Sports and Exercise
- Correlation of Somatostatin Receptor 1–5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms (2022)
- Cancers
- Diagnostic Accuracy of F-18-FDG-PET/CT and F-18-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI (2022)
- Contrast Media and Molecular Imaging
- Single Center Experience with a 4-Week 177Lu-PSMA-617 Treatment Interval in Patients with Metastatic Castration-Resistant Prostate Cancer (2022)
- Cancers
- Tietoruutu L62. Radioaktiiviset ligandit (2022) Farmakologia ja toksikologia Teräs Mika, Kemppainen Jukka
- A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE) (2021)
- European Urology Oncology
- More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond (2021)
- Cancers
UTU Research Portal